Qiagen N.V.
QGEN
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magneticā¦ read more
Healthcare
Diagnostics & Research
29 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$40.04
Price+1.83%
$0.72
1Y
Price
Market Cap
$8.251b
Mid
Price/Earnings 3y Avg5y Avg
19.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+15.8%
EBITDA Margin+20.0%
Net Profit Margin+21.7%
Free Cash Flow Margin+15.8%
EBITDA Margin+20.0%
Net Profit Margin+21.7%
Free Cash Flow MarginRevenue
$2.090b
+5.7%
1y CAGR-0.6%
3y CAGR-1.7%
5y CAGREarnings
$424.880m
+408.3%
1y CAGR+104.5%
3y CAGR+74.0%
5y CAGREPS
$2.04
+418.4%
1y CAGR+107.3%
3y CAGR+76.2%
5y CAGRBook Value
$3.778b
$6.296b
Assets$2.518b
Liabilities$1.654b
DebtDebt to Assets
26.3%
2.3x
Debt to EBITDAFree Cash Flow
$453.277m
-10.6%
1y CAGR+4.2%
3y CAGR+10.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company